[Federal Register Volume 83, Number 141 (Monday, July 23, 2018)]
[Notices]
[Pages 34875-34876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15721]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: VHG Labs DBA LGC 
Standards

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before August 22, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before August 22, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on April 
13, 2018, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchaster NH 
03103 applied to be registered as an importer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
      Controlled substance           Drug code           Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-              1233  I
 FMC).
Cathinone.......................            1235  I
Methcathinone...................            1237  I
4-Fluoro-N-methylcathinone (4-              1238  I
 FMC).
Pentedrone ([alpha]-                        1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-                     1248  I
 methylcathinone).
4-Methyl-N-ethylcathinone (4-               1249  I
 MEC).
Naphyrone.......................            1258  I
N-Ethylamphetamine..............            1475  I
4-Methylaminorex (cis isomer)...            1590  I
Methaqualone....................            2565  I
JWH-250 (1-Pentyl-3-(2-                     6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1-             7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
APINACA and AKB48 N-(1-                     7048  I
 Adamantyl)-1-pentyl-1H-indazole-
 3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4-                  7081  I
 methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-             7104  I
 Pentyl-3-[(4-methoxy)-benzoyl]
 indole.
JWH-018 (also known as AM678) (1-           7118  I
 Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-            7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-                7144  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanon
 e.
AM2201 (1-(5-Fluoropentyl)-3-(1-            7201  I
 naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2-                     7203  I
 chlorophenylacetyl) indole).
Ibogaine........................            7260  I
Lysergic acid diethylamide......            7315  I
2,5-Dimethoxy-4-(n)-                        7348  I
 propylthiophenethylamine (2C-T-
 7).
Marihuana.......................            7360  I
Mescaline.......................            7381  I
2-(4-Ethylthio-2,5-                         7385  I
 dimethoxyphenyl) ethanamine (2C-
 T-2 ).

[[Page 34876]]

 
4-Bromo-2,5-dimethoxyamphetamine            7391  I
4-Bromo-2,5-                                7392  I
 dimethoxyphenethylamine.
JWH-398 (1-Pentyl-3-(4-chloro-1-            7398  I
 naphthoyl) indole).
3,4-Methylenedioxyamphetamine...            7400  I
N-Hydroxy-3,4-                              7402  I
 methylenedioxyamphetamine.
3,4-Methylenedioxy-N-                       7404  I
 ethylamphetamine.
3,4-                                        7405  I
 Methylenedioxymethamphetamine.
4-Methoxyamphetamine............            7411  I
5-Methoxy-N-N-dimethyltryptamine            7431  I
Alpha-methyltryptamine..........            7432  I
Bufotenine......................            7433  I
Dimethyltryptamine..............            7435  I
Psilocyn........................            7438  I
N-Benzylpiperazine..............            7493  I
4-Methyl-                                   7498  I
 alphapyrrolidinopropiophenone
 (4-MePPP).
2-(2,5-Dimethoxy-4-ethylphenyl)             7509  I
 ethanamine (2C-E ).
2-(4-iodo-2,5-dimethoxyphenyl)              7518  I
 ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl)            7519  I
 ethanamine (2C-C).
MDPV (3,4-                                  7535  I
 Methylenedioxypyrovalerone).
2-(4-chloro-2,5-dimethoxyphenyl)-           7537  I
 N-(2-methoxybenzyl) ethanamine
 (25C-NBOMe).
Methylone (3,4-Methylenedioxy-N-            7540  I
 methylcathinone).
Butylone........................            7541  I
Pentylone.......................            7542  I
alpha-pyrrolidinopentiophenone              7545  I
 ([alpha]-PVP).
AM-694 (1-(5-Fluoropentyl)-3-(2-            7694  I
 iodobenzoyl) indole).
Codeine-N-oxide.................            9053  I
Desomorphine....................            9055  I
Dihydromorphine.................            9145  I
Heroin..........................            9200  I
Morphine-N-oxide................            9307  I
Normorphine.....................            9313  I
Pholcodine......................            9314  I
Dipipanone......................            9622  I
Properidine.....................            9644  I
Tilidine........................            9750  I
Alpha-methylfentanyl............            9814  I
Methamphetamine.................            1105  II
Phenmetrazine...................            1631  II
Amobarbital.....................            2125  II
Pentobarbital...................            2270  II
Secobarbital....................            2315  II
Glutethimide....................            2550  II
Phencyclidine...................            7471  II
Phenylacetone...................            8501  II
Alphaprodine....................            9010  II
Dihydrocodeine..................            9120  II
Diphenoxylate...................            9170  II
Ecgonine........................            9180  II
Ethylmorphine...................            9190  II
Levorphanol.....................            9220  II
Isomethadone....................            9226  II
Meperidine......................            9230  II
Meperidine intermediate-B.......            9233  II
Meperidine intermediate-C.......            9234  II
Dextropropoxyphene, bulk (non-              9273  II
 dosage forms).
14-Hydroxmorphone...............            9665  II
Noroxymorphone..................            9668  II
Remifentanil....................            9739  II
Sufentanil......................            9740  II
------------------------------------------------------------------------

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytical purposes. 
Placement of these drug codes onto the company's registration does not 
translate into automatic approval of subsequent permit applications to 
import controlled substance. Approval of permit applications will occur 
only when the registrant's business activity is consistent with what is 
authorized under 21 U.S.C. 952(a) (2). Authorization will not extend to 
the import of FDA approved or non- approved finished dosage forms for 
commercial sale.

    Dated: July 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-15721 Filed 7-20-18; 8:45 am]
 BILLING CODE 4410-09-P